Edition:
India

EMA Panel Recommends Conditional Approval Of Clovis Oncology Ovarian Cancer Drug Rubraca


Friday, 23 Mar 2018 

March 23 (Reuters) - EU Medicines Agency: :RECOMMENDS APPROVAL OF CLOVIS ONCOLOGY <<>> OVARIAN CANCER DRUG RUBRACA.EU MEDICINES AGENCY SAYS RECOMMENDED GRANTING A CONDITIONAL MARKETING AUTHORISATION FOR CLOVIS OVARIAN CANCER DRUG RUBRACA.